Showing results (341-350 of 514) with videos related to
Sort By:
Pageof 52
Inorganic Chemistry Frontiers|May 28, 2021
Development of a cobalt(iii)-based ponatinib prodrug systemMarlene Mathuber, Michael Gutmann, Mery La Franca, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 13, 2009
Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitroWolfgang Kandioller, Christian G Hartinger, Alexey A Nazarov, et al.Journal of Inorganic Biochemistry|May 8, 2014
Inductively coupled plasma mass spectrometry for metallodrug development: albumin binding and serum distribution of cytotoxic cis- and trans-isomeric platinum(II) complexesKonstantin Ossipov, Yulia Y Scaffidi-Domianello, Irina F Seregina, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|August 28, 2021
Estrone-salicylaldehyde N-methylated thiosemicarbazone hybrids and their copper complexes: solution structure, stability and anticancer activity in tumour spheroidsTatsiana V Petrasheuskaya, Debora Wernitznig, Márton A Kiss, et al.Journal of Medicinal Chemistry|April 15, 2005
Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potentialMichael A Jakupec, Erwin Reisner, Anna Eichinger, et al.Journal of Inorganic Biochemistry|June 13, 2012
Osmium(IV) complexes with 1H- and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activityGabriel E Büchel, Iryna N Stepanenko, Michaela Hejl, et al.Inorganic Chemistry|October 29, 2011
Organometallic 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as potential anticancer agentsIryna N Stepanenko, Maria S Novak, Gerhard Mühlgassner, et al.Dalton Transactions (Cambridge, England : 2003)|October 3, 2022
Novel oxaliplatin(IV) complexes conjugated with ligands bearing pendant 1,2-dithiolane/1,2-diselenolane/cyclopentyl motifsXiao Liu, Dominik Wenisch, Marie-Christin Barth, et al.Journal of Inorganic Biochemistry|August 30, 2006
Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteinsAlexander V Rudnev, Lidia S Foteeva, Christian Kowol, et al.European Journal of Medicinal Chemistry|July 15, 2018
Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interactionWojciech Streciwilk, Alessio Terenzi, Xinlai Cheng, et al.Pageof 52